<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR58">
 <label>58.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cao</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Bai</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Fan</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>H</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019</article-title>
  <source>Open Forum Infect Dis.</source>
  <year>2020</year>
  <volume>7</volume>
  <issue>3</issue>
  <fpage>102</fpage>
  <pub-id pub-id-type="doi">10.1093/ofid/ofaa102</pub-id>
 </element-citation>
</ref>
